- Home
- BCAX vs HEPS Comparison
BCAX vs HEPS Comparison
Compare BCAX & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAX
- HEPS
- Stock Information
- Founded
- BCAX 2018
- HEPS 2000
- Country
- BCAX United States
- HEPS Turkey
- Employees
- BCAX N/A
- HEPS N/A
- Industry
- BCAX
- HEPS Catalog/Specialty Distribution
- Sector
- BCAX
- HEPS Consumer Discretionary
- Exchange
- BCAX NYSE
- HEPS Nasdaq
- Market Cap
- BCAX 1.0B
- HEPS 1.0B
- IPO Year
- BCAX 2024
- HEPS 2021
- Fundamental
- Price
- BCAX $12.11
- HEPS $3.14
- Analyst Decision
- BCAX Strong Buy
- HEPS
- Analyst Count
- BCAX 5
- HEPS 0
- Target Price
- BCAX $41.33
- HEPS N/A
- AVG Volume (30 Days)
- BCAX 603.8K
- HEPS 567.3K
- Earning Date
- BCAX 02-16-2025
- HEPS 12-10-2024
- Dividend Yield
- BCAX N/A
- HEPS N/A
- EPS Growth
- BCAX N/A
- HEPS N/A
- EPS
- BCAX N/A
- HEPS N/A
- Revenue
- BCAX N/A
- HEPS $1,167,077,294.00
- Revenue This Year
- BCAX N/A
- HEPS $44.03
- Revenue Next Year
- BCAX N/A
- HEPS $37.67
- P/E Ratio
- BCAX N/A
- HEPS N/A
- Revenue Growth
- BCAX N/A
- HEPS 82.39
- 52 Week Low
- BCAX $11.56
- HEPS $1.25
- 52 Week High
- BCAX $28.09
- HEPS $4.05
- Technical
- Relative Strength Index (RSI)
- BCAX N/A
- HEPS 50.28
- Support Level
- BCAX N/A
- HEPS $3.01
- Resistance Level
- BCAX N/A
- HEPS $3.15
- Average True Range (ATR)
- BCAX 0.00
- HEPS 0.14
- MACD
- BCAX 0.00
- HEPS -0.02
- Stochastic Oscillator
- BCAX 0.00
- HEPS 40.00
About BCAX BICARA THERAPEUTICS INC
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues, and other revenues.